Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.

Liu C, Xu Y, Cui L, Wang J, Peng B, Zhong L, Chen X.

J Clin Neurosci. 2013 Feb;20(2):278-80. doi: 10.1016/j.jocn.2012.02.042. Epub 2012 Nov 17.

PMID:
23164828
2.

Serum uric acid levels and neuromyelitis optica.

Peng F, Zhong X, Deng X, Qiu W, Wu A, Long Y, Hu X, Li Q, Jiang Y, Dai Y.

J Neurol. 2010 Jun;257(6):1021-6. doi: 10.1007/s00415-010-5455-1. Epub 2010 Jan 22.

PMID:
20094725
3.

[Serum uric acid level and related clinical features in neuromyelitis optica].

You XF, Ye J, Qin W, Zhao WH, Hao YG, Hu WL.

Zhonghua Nei Ke Za Zhi. 2010 Nov;49(11):935-8. Chinese.

PMID:
21211206
4.

Correlations between serum uric acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis.

Liu CY, Xu Y, Cui LY, Peng B, Zhong LZ, Chen XW, Wang JM.

Chin Med Sci J. 2012 Jun;27(2):88-91.

PMID:
22770406
5.

Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.

Min JH, Waters P, Vincent A, Lee S, Y Shin H, H Lee K, Kim BJ.

Acta Neurol Scand. 2012 Oct;126(4):287-91. doi: 10.1111/j.1600-0404.2012.01643.x. Epub 2012 Feb 6.

PMID:
22309305
6.

Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability.

Tomizawa Y, Yokoyama K, Saiki S, Takahashi T, Matsuoka J, Hattori N.

J Int Med Res. 2012;40(4):1483-91.

PMID:
22971500
7.

Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.

Tortorella C, Ruggieri M, Di Monte E, Ceci E, Iaffaldano P, Direnzo V, Mastrapasqua M, Frigeri A, Amato MP, Hakiki B, Ghezzi A, Lugaresi A, De Luca G, Patti F, D'Amico E, Sola P, Simone AM, Svelto M, Livrea P, Trojano M.

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1355-9. doi: 10.1136/jnnp.2011.241836. Epub 2011 May 27.

PMID:
21622936
8.

Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica.

Peng F, Yang Y, Liu J, Jiang Y, Zhu C, Deng X, Hu X, Chen X, Zhong X.

Eur J Neurol. 2012 Feb;19(2):277-83. doi: 10.1111/j.1468-1331.2011.03488.x. Epub 2011 Jul 30.

PMID:
21801283
9.

Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.

Chang KH, Tseng MY, Ro LS, Lyu RK, Tai YH, Chang HS, Wu YR, Huang CC, Hsu WC, Kuo HC, Chu CC, Chen CM.

Clin Chim Acta. 2013 Feb 18;417:26-30. doi: 10.1016/j.cca.2012.12.008. Epub 2012 Dec 21.

PMID:
23262373
10.

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.

Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B.

J Neurol Sci. 2011 Jul 15;306(1-2):82-90. doi: 10.1016/j.jns.2011.03.038. Epub 2011 May 6.

PMID:
21550068
11.

Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.

Wu A, Zhong X, Wang H, Xu W, Cheng C, Dai Y, Bao J, Qiu W, Lu Z, Hu X.

Can J Neurol Sci. 2012 Nov;39(6):813-20.

PMID:
23041403
12.

Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.

Zhong X, Wang H, Dai Y, Wu A, Bao J, Xu W, Cheng C, Lu Z, Qiu W, Hu X.

J Neuroimmunol. 2011 Dec 15;240-241:104-8. doi: 10.1016/j.jneuroim.2011.10.001. Epub 2011 Oct 28.

PMID:
22036953
13.

Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.

Wang H, Wang K, Zhong X, Dai Y, Qiu W, Wu A, Hu X.

Neuroimmunomodulation. 2012;19(5):304-8. doi: 10.1159/000339302. Epub 2012 Jul 6.

PMID:
22777162
14.

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.

Kim SM, Waters P, Vincent A, Go MJ, Park KS, Sung JJ, Lee KW.

J Neurol. 2011 Dec;258(12):2176-80. doi: 10.1007/s00415-011-6086-x. Epub 2011 May 19.

PMID:
21594697
15.

Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.

Shu Y, Li R, Yang Y, Dai Y, Qiu W, Chen Y, Zhao Z, Lu Z, Hu X.

Neurochem Int. 2015 Feb;81:28-31. doi: 10.1016/j.neuint.2014.12.008. Epub 2014 Dec 30.

PMID:
25555815
16.

Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica.

Zhong XN, Wang HH, Bao J, Li R, Long YM, Lu ZQ, Dai YQ, Qiu W, Hu XQ.

Chin Med J (Engl). 2012 Jan;125(2):270-4.

PMID:
22340558
17.

Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.

Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F; Spanish-Italian NMO Study Group.

J Neurol. 2007 Sep;254(9):1233-7. Epub 2007 Apr 2.

PMID:
17401734
18.

Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.

Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1164-7. doi: 10.1001/archneurol.2009.188.

PMID:
19752309
19.

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.

Takano R, Misu T, Takahashi T, Sato S, Fujihara K, Itoyama Y.

Neurology. 2010 Jul 20;75(3):208-16. doi: 10.1212/WNL.0b013e3181e2414b.

PMID:
20644148
20.

Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.

Shimizu Y, Ota K, Ikeguchi R, Kubo S, Kabasawa C, Uchiyama S.

J Neuroimmunol. 2013 Oct 15;263(1-2):148-51. doi: 10.1016/j.jneuroim.2013.07.005. Epub 2013 Jul 30.

PMID:
23910387
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk